With the latest batch of quarterly operating results behind most companies and rising economic anxiety across the globe, it’s likely that most stocks will be driven by macro and sector-specific forces in the near term. But that may not be true for…
Events taking place this September have the potential to leave a lasting mark on the two businesses. Renewable Energy Group’s long-term future — and a pending $370 million windfall — could be heavily influenced by Congress returning to session after its summer recess. Meanwhile, U.S. regulators will hand down a decision on Novo Nordisk’s most important drug candidate, oral semaglutide, by the end of the month. Some analysts expect the drug to deliver peak annual sales of $5 billion, which would inject much-needed growth into the pharma giant.
Here’s why investors looking for a little excitement should watch these two stocks this September.
Can the trade war save the biodiesel industry?
There’s no end in sight for the trade war between the United States and China. While Washington is holding all the cards from a geopolitical perspective, Beijing has still managed to inflict pain on its counterpart by sharply reducing imports of agricultural products. It hurts because agricultural products were the only trade category (excluding services) in which Uncle Sam had consistently run a surplus in recent years.
The economic burden caused by diminished access to global markets has fallen on American farmers, who’ve also had to deal with record flooding and uncertainty in the biofuels markets. The government cannot control the weather, and it seems invested in the trade war. That leaves biofuels markets, and especially the biodiesel industry, as one obvious lever to pull in any relief package extended to farmers.
Consider that the existence of America’s biodiesel industry creates a market for soy oil and incentivizes soybean crushing, both of which used to be a net cost to farmers. But Congress allowed an important biodiesel tax credit to expire at the end of 2017. That’s led to curtailed biodiesel production, which has put pressure on an important domestic market for farmers just as they’re losing access to China.
That’s also hurt Renewable Energy Group, which is North America’s largest producer of biodiesel. The business reported an operating loss of $92 million in the first half of 2019 but estimates it would receive a $370 million windfall if Congress reinstates the tax credit. The company desperately needs the cash injection to invest in renewable diesel opportunities and outgrow the uncertainty of biodiesel markets for good.
Congress will be back in session in September following a monthlong recess. If an economic relief package is extended to farmers, then there’s a solid chance it’ll include retroactive reinstatement of the biodiesel tax credit, which has strong bipartisan support. There’s no guarantee, but investors should expect the biodiesel industry to capitalize on its limited window of opportunity. In a strange, twisted way, the trade war might actually help biodiesel producers…
Continue reading at THE MOTLEY FOOL